Literature DB >> 18158349

Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet.

Sarah F Knight1, Jeffrey E Quigley, Jianghe Yuan, Siddhartha S Roy, Ahmed Elmarakby, John D Imig.   

Abstract

Obesity and hypertension have been identified as cardiovascular risk factors that contribute to the progression of end-stage renal disease. To examine the mechanisms by which a high-fat diet and hypertension contribute to endothelial dysfunction and renal injury, 8-week-old male spontaneously hypertensive rats and Wistar rats were fed a high-fat (36% fat) or a normal-fat (7% fat) diet for 10 weeks. The high-fat diet increased body weight in Wistar and hypertensive rats by 25 and 31 g, respectively. Systolic blood pressure was higher in the hypertensive rats compared with Wistar rats; however, blood pressure was unaltered by the high-fat diet. Afferent arteriole response to acetylcholine was impaired in the high-fat groups after just 3 weeks. Renal macrophage infiltration was increased in the hypertensive high-fat group compared with others, and monocyte chemoattractant protein-1 excretion was increased in both of the high-fat-fed groups. Renal PCR arrays displayed significant increases in 2 inflammatory genes in hypertensive rats fed a normal diet, 1 gene was increased in high-fat-fed Wistar rats, whereas 12 genes were increased in high-fat-fed hypertensive rats. Urinary albumin excretion was increased in the hypertensive rats compared with the Wistar rats, which was further exacerbated by the high-fat diet. Glomerular nephrin expression was reduced and desmin was increased by the high-fat diet in the hypertensive rats. Our results indicate that endothelial dysfunction precedes renal injury in normotensive and spontaneously hypertensive rats fed a high-fat diet, and hypertension with obesity induces a powerful inflammatory response and disruption of the renal filtration barrier.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18158349      PMCID: PMC2491336          DOI: 10.1161/HYPERTENSIONAHA.107.099499

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  43 in total

1.  Inflamed fat: what starts the fire?

Authors:  Jaap G Neels; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

2.  Altered renal microvascular response in Zucker obese rats.

Authors:  Koichi Hayashi; Takeshi Kanda; Koichiro Homma; Hirobumi Tokuyama; Ken Okubo; Ichiro Takamatsu; Satoru Tatematsu; Hiroo Kumagai; Takao Saruta
Journal:  Metabolism       Date:  2002-12       Impact factor: 8.694

3.  Immunosuppressive treatment protects against angiotensin II-induced renal damage.

Authors:  Dominik N Muller; Erdenechimeg Shagdarsuren; Joon-Keun Park; Ralf Dechend; Eero Mervaala; Franziska Hampich; Anette Fiebeler; Xinsheng Ju; Piet Finckenberg; Jürgen Theuer; Christiane Viedt; Joerg Kreuzer; Harald Heidecke; Hermann Haller; Martin Zenke; Friedrich C Luft
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

4.  HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.

Authors:  S Wassmann; U Laufs; A T Bäumer; K Müller; K Ahlbory; W Linz; G Itter; R Rösen; M Böhm; G Nickenig
Journal:  Hypertension       Date:  2001-06       Impact factor: 10.190

Review 5.  Obesity-associated hypertension and kidney disease.

Authors:  John E Hall; Jay J Kuo; Alexandre A da Silva; Rogerio B de Paula; Jiankang Liu; Lakshmi Tallam
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-03       Impact factor: 2.894

6.  Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria.

Authors:  Josephine M Forbes; Fabrice Bonnet; Leileata M Russo; Wendy C Burns; Zemin Cao; Riccardo Candido; Hiroshi Kawachi; Terri J Allen; Mark E Cooper; George Jerums; Tanya M Osicka
Journal:  J Hypertens       Date:  2002-05       Impact factor: 4.844

7.  N-linked glycosylation is critical for the plasma membrane localization of nephrin.

Authors:  Kunimasa Yan; Jamshid Khoshnoodi; Vesa Ruotsalainen; Karl Tryggvason
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

8.  Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A.

Authors:  S I Yamagishi ; D Edelstein; X L Du; Y Kaneda; M Guzmán; M Brownlee
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

9.  Nucleotide variation, haplotype structure, and association with end-stage renal disease of the human interleukin-1 gene cluster.

Authors:  Jeannette T Bensen; Carl D Langefeld; Gregory A Hawkins; Linda E Green; Josyf C Mychaleckyj; Catherine S Brewer; Deborah S Kiger; Scott M Binford; Carla J Colicigno; Dax C Allred; Barry I Freedman; Donald W Bowden
Journal:  Genomics       Date:  2003-08       Impact factor: 5.736

10.  Murine CCR9, a chemokine receptor for thymus-expressed chemokine that is up-regulated following pre-TCR signaling.

Authors:  A M Norment; L Y Bogatzki; B N Gantner; M J Bevan
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

View more
  41 in total

1.  A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat.

Authors:  Md Abdul Hye Khan; Sung Hee Hwang; Amit Sharma; John A Corbett; Bruce D Hammock; John D Imig
Journal:  Prostaglandins Other Lipid Mediat       Date:  2016-07-16       Impact factor: 3.072

2.  Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet.

Authors:  Islam N Mohamed; Sherif S Hafez; Arwa Fairaq; Adviye Ergul; John D Imig; Azza B El-Remessy
Journal:  Diabetologia       Date:  2013-11-08       Impact factor: 10.122

Review 3.  Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Brianca Fizer; Alyssa Pennington; Ashley Szabo-Johnson; Willie L Thompson; Denise C Cornelius; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

4.  Obesity and kidney disease: hidden consequences of the epidemic.

Authors:  Csaba P Kovesdy; Susan L Furth; Carmine Zoccali
Journal:  Pediatr Nephrol       Date:  2017-02-01       Impact factor: 3.714

5.  Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib.

Authors:  Tasuku Nagasawa; Md Abdul Hye Khan; John D Imig
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-05       Impact factor: 2.557

Review 6.  Obesity and kidney disease: hidden consequences of the epidemic.

Authors:  Csaba P Kovesdy; Susan L Furth; Carmine Zoccali
Journal:  J Nephrol       Date:  2017-02       Impact factor: 3.902

7.  EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels.

Authors:  Komal Sodhi; Nitin Puri; Kazuyoshi Inoue; John R Falck; Michal L Schwartzman; Nader G Abraham
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-12-24       Impact factor: 3.072

8.  Is longitudinal pulse pressure a better predictor of 24-hour urinary albumin excretion than other indices of blood pressure?

Authors:  S Morteza Farasat; Carolina Valdes; Veena Shetty; Denis C Muller; Josephine M Egan; E Jeffrey Metter; Luigi Ferrucci; Samer S Najjar
Journal:  Hypertension       Date:  2009-12-14       Impact factor: 10.190

9.  Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension.

Authors:  Sarah F Knight; Jianghe Yuan; Siddhartha Roy; John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

10.  Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats.

Authors:  John D Imig; Katie A Walsh; Md Abdul Hye Khan; Tasuku Nagasawa; Mary Cherian-Shaw; Sean M Shaw; Bruce D Hammock
Journal:  Exp Biol Med (Maywood)       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.